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a b s t r a c t
Silver nanoparticles (AgNPs) were synthesised by reducing silver salts using NaBH4 followed by capping
with varying concentrations of -cyclodextrin (-CD) and were physically characterised. Antibacterial
activity against Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus was determined by
a microtitre well method. The AgNPs were spherical under transmission electron microscopy, whilst
dynamic light scattering showed average diameters of capped particles to be smaller (4–7nm) than their
uncapped equivalents (17nm). Capped particles demonstrated superior photostability when exposed to
intense ultraviolet radiation for 4h as well as significantly (P<0.05) higher (up to 3.5-fold) antibacterial
activity. The influence of -CD concentration was seen to delay bacterial growth, indicating that a Trojan
horse mechanism may be occurring owing to bacterial carbohydrate affinity, thereby enhancing silver
ion absorption.
© 2010 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
1. Introduction
The persistence of antibiotic-resistant bacteria has renewed
interest in the use of silver and silver-based compounds, includ-
ing silver nanoparticles (AgNPs), as alternative antibacterial agents.
Such compounds can reduce infections in burns patients and
prevent bacterial colonisation of prostheses, catheters, dental
materials and human skin. The high thermal stability, low toxicity
to human cells and effective broad-spectrum antibacterial activity
ofAgNPs [1] havebeenexploited in a rangeof commercial products.
There are several hypotheses to explain theantibacterial activity
of AgNPs. Their rapid breakdown releases ionic silver that inac-
tivates vital bacterial enzymes by interacting with essential thiol
groups. Silver ions can inhibit bacterial DNA replication, damaging
bacterial cytoplasmic membranes, depleting levels of intracellu-
lar adenosine triphosphate (ATP) and causing cell death [2]. The
high specific surface-to-volume ratio of AgNPs increases their con-
tact with microorganisms, promoting the dissolution of silver ions,
thereby improving biocidal effectiveness. The ability of AgNPs to
release silver ions is key to their antibacterial activity [3].
AgNPs can be synthesised in a number of ways, with boro-
hydride reduction of silver salts being the most common.
Stabilisation is achieved using capping agents that bind to the
nanoparticle surface and improve stability and water solubility,
∗ Corresponding author. Tel.: +353 1 402 7964.
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which are essential to prevent aggregation; examples include
water-soluble polymers, oligosaccharides and polysaccharides,
sodium dodecyl sulphate (SDS) and sophorolipid (glycolipid)
[4].
Cyclodextrins (CDs) are a family of soluble, non-toxic molecules
consisting of 6, 7 or 8 d-glucopyranosyl residues (denoted as -,
- and -CDs, respectively) linked in cyclic structure by -1,4 gly-
cosidic bonds. They can form inclusion complexes incorporating
various molecular guests within their hollow, truncated cone-
shaped cavity structure, enabling them to be used as drug carriers
and enzyme mimics. Host–guest interaction has been attributed to
a combination of weak interactions such as van der Waals forces,
hydrogen bonding and hydrophobic interactions [5]. Of the three
cyclodextrins,-CD, with an internal cavity diameter of 0.78nm, is
the most widely used but is too small to entrap AgNPs and simply
binds via chemisorption to the nanoparticles through rim hydroxyl
groups.
Unmodified -CD has been used to prepare silver and gold
nanoparticles in the presence of different reducing agents such
as ethanol, dimethylformamide, ethylene glycol and sodium cit-
rate. Little has been published on the antimicrobial activity of
unmodified CDs, but modified -CD (dimethylated -CD) inhib-
ited growth of Rhodococcus erythropolis and hydroxypropyl--CD
was toxic for Mycoplasma capricolum and Acholeplasma laidlawii,
whilst methylated -CD altered growth and cell envelope features
of Mycobacterium sp. [6].
The present work investigated AgNP synthesis using dif-
ferent concentrations of unmodified -CD with NaBH4 as the
0924-8579/$ – see front matter © 2010 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
doi:10.1016/j.ijantimicag.2010.05.006
Please cite this article in press as: Jaiswal S, et al. Enhancement of the antibacterial properties of silver nanoparticles using -cyclodextrin as a
capping agent. Int J Antimicrob Agents (2010), doi:10.1016/j.ijantimicag.2010.05.006
ARTICLE IN PRESSGModelANTAGE-3322; No.of Pages4
2 S. Jaiswal et al. / International Journal of Antimicrobial Agents xxx (2010) xxx–xxx
reducing agent. AgNPs were characterised by ultraviolet–visible
(UV–Vis) spectrometry, Fourier transform infrared spectroscopy
(FT-IR), dynamic light scattering (DLS) and transmission elec-
tron microscopy (TEM). Antibacterial activities of uncapped
and -CD-capped AgNPs against Gram-negative (Escherichia coli
and Pseudomonas aeruginosa) and Gram-positive (Staphylococcus
aureus) bacteria were determined.
2. Materials and methods
2.1. Synthesis of silver nanoparticles
Aqueous -CD solutions (5, 10 and 20mM) were stirred into
equal volumes of 2mMAgNO3 for 15min and equal volumes of ice-
cold 20mMNaBH4 were added. Resultant solutionswere stabilised
by stirring (24h). The final molar ratios of -CD:AgNO3 were 2.5,
5 and 10 to 1, respectively. A -CD-free control was similarly pre-
pared. All chemicals were purchased from Sigma-Aldrich (Dublin,
Ireland) and were used without further purification.
2.2. Sample characterisation
UV–Vis absorption spectra of -CD-capped AgNPs were
acquired in the 300–800nm wavelength range using an
UV–Vis–NIR spectrophotometer (Perkin-Elmer Lambda 900;
Perkin-Elmer) operating at a resolution of 2nm. FT-IR spectra
were measured in the 4000–400 cm−1 range with a resolution of
1 cm−1 using a Perkin-Elmer Spectrum GX instrument in trans-
mission mode using potassium bromide (KBr) pellets prepared by
mixing KBr powder with AgNP solutions and then drying (24h,
100 ◦C). AgNP morphology was determined using a JEM-100CX II
transmission electron microscope (JEOL) operated at an acceler-
ating voltage of 100kV. Samples were drop-cast onto standard
Formvar-coated copper grids (200–300nm) and then air dried. The
average particle size (hydrodynamic diameter) was determined at
25 ◦C by DLS using a Malvern Zetasizer Nano instrument (Malvern
Instruments) equipped with a 4mW He–Ne laser and measured
using an automatic mode with a scattering angle of 90◦. Sample
photostability was determined by exposing solutions to an intense
UV source (Q-sun Xenon Test Chamber; Q-Lab) operating at
0.4W/m2 (340nm) for 1, 2, 3 and 4h, respectively.
2.3. Bacterial strains and growth conditions
Gram-negative bacteria (E. coli ATCC 11229 and P. aeruginosa
ATCC 27852) and Gram-positive bacteria (S. aureus ATCC 25923)
were grown, subcultured and maintained on Mueller–Hinton agar
(Lab M) and stored at 4 ◦C. For the experiment, a single colony of
each organism was inoculated into 10mL of Mueller–Hinton broth
(MHB) and incubated overnight at 37 ◦C with shaking at 200 rpm.
Theoptical density of the overnight culturewas adjusted to that of a
0.5 McFarland standard [1.5×108 colony-forming units (CFU)/mL]
using a Densimat photometer (bioMérieux, France) and diluted
with MHB to give a final working concentration of 1×106 CFU/mL.
2.4. Antibacterial activity assay
Antibacterial activities of capped and uncapped AgNPs of dif-
ferent silver concentrations were determined by a microtitre well
method [7]. Samples were doubly diluted in water (100L) in
microtitre wells and bacteria (100L; 106 CFU/mL) were added.
Negative (AgNPs 100L + sterile MHB 100L) and positive (ster-
ile MHB 100L +bacterial suspension 100L) control wells and a
sterility control blank (sterile MHB 200L) were included in each
assay. Plates were incubated (18h) in a microtitre plate reader
(PowerWaveTM Microplate spectrophotometer; BioTek, Winooski,
VT) at 37 ◦C. Samples were tested in duplicate on each plate and
each plate was analysed in triplicate.
2.5. Data analysis
2.5.1. Percentage inhibition of growth
AgNPantibacterial activitiesweredeterminedby calculating the
percentage inhibition of growth using the formula [7]:
I% = (C18 − C0) − (T18 − T0)
(C18 − C0)
100
where I is the percentage inhibition of growth, C18 is the blank-
compensated optical density at 600nm (OD600) of the positive
control of the organism at 18h, C0 is the blank-compensated OD600
of the positive control of the organism at 0h, T18 is the negative
control-compensated OD600 of the organism in the presence of test
sample at 18h, and T0 is the negative control-compensated OD600
of the organism in the presence of test sample at 0h.
2.5.2. Kinetic measurement of bacterial growth
Bacterial concentrations in the presence of capped and
uncapped AgNPs were determined over time by measuring the
OD600 every 30min following 30 s of agitation. Antibacterial kinet-
ics was analysed graphically as a plot of contact time versus OD600.
2.5.3. Statistical analysis
Statistical differences between multiple comparisons were
evaluated using analysis of variance (ANOVA) followed by least
significant difference testing. All statistical analyses were carried
out using STATGRAPHICS centurion XV. A P-value of <0.05 was
considered statistically significant.
3. Results and discussion
3.1. Characterisation of ˇ-cyclodextrin-capped silver
nanoparticles
All AgNPs showed a surface plasmon absorption band around
400nm as expected for colloidal AgNPs, indicating roughly spheri-
cal nanoparticles, whilst solution absorbance intensities increased
with -CD concentration. Since the intensity of the plasmon reso-
nance band depends on particle size, shape, metallic material and
its surrounding environment, the number of particles cannot be
related linearly to the absorbance intensities [8].
3.2. Ultraviolet stability
On exposure to intense UV radiation the colour of uncapped
AgNPs became darker, with the absorbance peak becoming
14.05nm broader (with respect to peak width at half maximum)
over time. There were no significant changes in absorbance at the
higher-CD concentrations, although at 5mM it increased slightly.
This confirmed that uncapped AgNPs continued to grow and/or
aggregate over time, whilst AgNPs capped at appropriate -CD
concentrations exhibited good stability.
3.3. Silver nanoparticle–ˇ-cyclodextrin binding
FT-IR confirmed -CD binding to the AgNP surface. The free
-CD spectrum showed bands at 947 cm−1 (skeletal vibration
involving  1–4 linkage) and 756 cm−1 (ring breathing vibration),
whilst bands at 708 cm−1 and 579 cm−1 were assigned to pyranose
ring vibration [9]. Comparison of the spectra of 20mM -CD-
capped AgNPs and free -CD showed a decrease in the relative
intensitiesof transmittancebandsat947 cm−1, 756 cm−1, 708 cm−1
and 579 cm−1 and a suppression of the –OH vibrational band at
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Table 1
Percentage growth inhibition of Pseudomonas aeruginosa, Escherichia coli and Staphylococcus aureus in the presence of uncapped and -cyclodextrin (-CD)-capped (5, 10
and 20mM) silver nanoparticles (AgNPs) containing different silver concentrationsa.
Microorganism Sample [Ag]
100ppm 50ppm 25ppm 12.5ppm 6.25ppm 3.12ppm
P. aeruginosa 20 mM -CD–AgNPs 99.72 ± 0.2 96.11 ± 3.7 98.36 ± 1.1 99.24 ± 0.5 N/D N/D
P. aeruginosa 10 mM -CD–AgNPs 99.08 ± 0.8 98.59 ± 1.5 98.34 ± 1.4 97.27 ± 0.7 N/D N/D
P. aeruginosa 5 mM -CD–AgNPs 99.85 ± 0.4 97.23 ± 1.5 98.37 ± 1.1 64.50 ± 6.2 N/D N/D
P. aeruginosa Uncapped AgNPs 97.40 ± 2.2 96.55 ± 1.3 96.23 ± 3.1 13.92 ± 6.6 N/D N/D
E. coli 20 mM -CD–AgNPs 99.19 ± 0.3 96.81 ± 2.9 96.91 ± 1.6 98.40 ± 0.7 53.45±4.8 34.84±5.8
E. coli 10 mM -CD–AgNPs 100 ± 0 96.96 ± 2.9 97.01 ± 1.4 97.02 ± 0.6 43.66±3.3 20.09±4.6
E. coli 5 mM -CD–AgNPs 99.59 ± 0.4 97.38 ± 3.3 97.91 ± 2.0 97.39 ± 0.2 29.28±10.9 19.38±3.2
E. coli Uncapped AgNPs 100 ± 0 96.52 ± 2.4 97.73 ± 0.7 97.58 ± 2.3 22.75±10.3 17.3±1.0
S. aureus 20 mM -CD–AgNPs 99.76 ± 0.3 97.75 ± 2.6 96.99 ± 1.2 97.48 ± 0.8 97.14±0.9 46.96±14.6
S. aureus 10 mM -CD–AgNPs 99.06 ± 0.8 97.50 ± 0.8 98.14 ± 1.6 97.4 ± 0.8 93.97±3.2 26.68±10.5
S. aureus 5 mM -CD–AgNPs 98.62 ± 1.0 98.46 ± 1.5 97.04 ± 0.9 96.98 ± 0.9 66.58±12.8 18.245±6.3
S. aureus Uncapped AgNPs 98.40 ± 0.8 97.31 ± 1.9 97.46 ± 1.0 96.88 ± 0.9 59.50±7.6 16.97±7.6
N/D, no growth inhibition detected.
a All values are the mean± standard deviation of two parallel experiments performed in triplicate.
3400 cm−1, indicating deprotonation of the hydroxyl groups [10] at
the rim of the CD structure. This suggests that there is chemisorp-
tion between the CD molecules and AgNPs via the rim hydroxyl
groups. Sorption of CDs might be due to binding of the AgNPs to
hydroxyl groups at positions C2 or C3. The oxyanion thus formed is
less nucleophilic than the non-deprotonated hydroxyl at position
C6 [11] and is therefore more likely to bind to the AgNPs.
3.4. Particle sizing
TEM micrographs of capped and uncapped AgNPs showed them
to be nearly spherical in shape, with the average size decreasing
with increasing -CD capping. DLS showed particles sizes of 6.2,
5.1 and 4.0nm for -CD-capped AgNPs (5, 10 and 20mM, respec-
tively) and 16.3nm for the uncapped particle. The capped AgNPs
were much larger in size than the -CD cavity (0.78nm), indicat-
ing chemisorption interaction through the CD rim hydroxyls rather
than encapsulation.
3.5. Antibacterial activity
Most published AgNP antibacterial studies have used plate
counting [12] and agar diffusion methods. Fewer reports have
used the quantitative microtitre well dilution method. The
effect of -CD capping on antibacterial activity was deter-
mined by comparing the percentage inhibition of bacterial
growth by uncapped AgNPs compared with that of capped
AgNPs (5, 10 and 20mM -CD) using a range of Ag con-
centrations (100, 50, 25, 12.5, 6.25 and 3.12ppm) detailed in
Table 1.
-CD-capped AgNPs displayed significantly (P<0.05) greater
antibacterial activity against P. aeruginosa than uncapped AgNPs.
AgNPs capped with 20mM and 10mM -CD had the strongest
activity of 99.2% and 97.3% inhibition, respectively, at 12.5ppm
[Ag], whereas inhibition for AgNPs capped with 5mM -CD was
64.5% and for uncapped AgNPs was 13.9%. Both capped and
uncapped AgNPs with a [Ag] ≥25ppm significantly inhibited
Fig. 1. Growth curves of (a, b) Pseudomonas aeruginosa in the presence of 6.25ppm [Ag] (a) and 3.12ppm [Ag] (b), (c, d) Escherichia coli in the presence of 6.25ppm [Ag] (c)
and 3.12ppm [Ag] (d) and (e, f) Staphylococcus aureus in the presence of 6.25ppm [Ag] (e) and 3.12ppm [Ag] (f). () 20mM -cyclodextrin (-CD); (©) 10mM -CD; (×)
5mM -CD; () 0mM -CD; and () Ag/-CD-free control. OD, optical density.
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Fig. 2. Proposed bacterial interaction with -cyclodextrin (-CD)-capped silver nanoparticles (AgNPs).
bacterial growth, whilst those with a [Ag] ≤6.25ppm showed no
inhibition.
Escherichia coli was 97% inhibited at a [Ag] of ≥12.5ppm. Below
this there was a variation in inhibition, with 20mM -CD-capped
AgNPs achieving 53.5% inhibition at 6.25ppm, whereas uncapped
AgNPs showed only 22.8% inhibition.
Staphylococcus aureus was 97.1% inhibited by 20mM -CD-
cappedAgNPs at a [Ag] of 6.25ppmcomparedwith 59.5% inhibition
by uncapped AgNPs. Antibacterial activity was high (94.0% inhibi-
tion) even at a concentration of 10mM-CD. Similar findings were
obtained with a [Ag] of 3.12ppm.
Antibacterial activity increasedwith corresponding rises in both
silver and cyclodextrin concentrations in all cases. Importantly, -
CD alone showed no antibacterial activity.
Bacterial growth curves showed that theAgNPs delayed growth.
The 20mM and 10mM -CD-capped AgNPs containing a [Ag]
of 6.25ppm completely inhibited P. aeruginosa growth until 18h
(Fig. 1a) compared with ca. 10h for the uncapped AgNPs. Even
at a [Ag] of 3.12ppm the 20mM -CD-capped AgNPs were more
effective than uncapped AgNPs (Fig. 1b). The 20mM -CD-capped
AgNPs at a [Ag] of 6.25ppm exhibited superior antibacterial activ-
ity against E. coli compared with uncapped AgNPs, delaying growth
for 9h versus 4.5h (Fig. 1c). A similar trend was observed for the
10mMand5mM-CD-cappedAgNPs. At a [Ag] of 6.25ppm,AgNPs
capped with 20mM and 10mM -CD delayed growth of S. aureus
for 17h (Fig. 1e). At a [Ag] of 3.12ppmcappingdoubledgrowth inhi-
bition (Fig. 1f). Overall, the duration of the lag growth phase of the
test organismswhen grown in the presence of AgNPswith different
[Ag] increased as the -CD capping concentration increased.
The increased antibacterial activity of -CD-capped AgNPs may
be attributed to a biodegradable capping agent forming smaller
nanoparticles without aggregation. These have a high surface-to-
volume ratio and undergo a higher level of interaction with the
bacterial cell surface than the larger uncapped AgNPs, resulting in
a higher antibacterial activity.
It is proposed that intimate contact between AgNPs and organ-
ismsmay enhance the transfer of Ag ions to the bacterial cell,whilst
bacterial degradation of the -CD saccharide promotes the release
of silver ions (Fig. 2) [13]. Such interactions have been described as
Trojan-horse mechanisms and have been reported in the literature
where fetal bovine serum was used to improve AgNP efficacy [14].
These results are in accordance with a previous report in which
AgNPs synthesised by disaccharides had higher antibacterial activ-
ities than those synthesised by monosaccharides [15].
4. Conclusion
In summary, there was an increase in the antibacterial activity
of-CD-cappedAgNPs comparedwith their uncapped equivalents.
This activity increasedas theconcentrationof-CD increased. Thus,
-CD capping can be used to achieve higher antibacterial efficacies
at lower metal ion concentrations.
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